OncoRes Medical Archives - Medical Design Sourcing

Combining optical coherence tomography imaging (OCT; left) with micro-elastography technologies, OncoRes’ quantitative micro-elastography (QME) imaging system provides real-time tumor assessment that helps surgeons more accurately identify and remove cancerous tissue. (Image courtesy of OncoRes Medical)

OncoRes Medical announced that it raised $12.5 million for its handheld imaging device for identifying cancer cells.

Perth, Western Australia-based OncoRes designed its imaging system to facilitate real-time tumor assessment, helping surgeons more accurately identify and remove cancerous tissue, including for breast cancer. The company won FDA breakthrough device designation in October 2020 for the device aimed at enabling surgeons to remove all cancer on the first try, thus avoiding a second procedure.

When the handheld probe is applied to a region of interest, it provides micro-scale maps of the stiffness of the tissue — a key differentiator from healthy tissu…

OncoRes Medical’s system may detect cancer cells on a microscopic scale during a lumpectomy, potentially averting the need for a second breast cancer surgery.

Having breast surgery to remove a cancerous lump is traumatic enough. Learning that you’ll need another operation to remove cancer cells that the surgeon couldn’t detect the first time only adds to the worry — and the cost.

Australian startup OncoRes Medical won FDA breakthrough device designation in October 2020 for its handheld imaging device designed to identify residual cancer cells in breast tissue after the surgeon has removed a tumor but before concluding the procedure. The idea is to enable surgeon…

OncoRes Medical

OncoRes Medical raises another $12.5M

This imaging device could be a breast cancer treatment breakthrough